Estrace is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Estradiol.
Product ID | 0430-0721_2aa67dc3-6945-4eb5-bb42-e2901a4dbd14 |
NDC | 0430-0721 |
Product Type | Human Prescription Drug |
Proprietary Name | Estrace |
Generic Name | Estradiol |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2011-12-26 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA040197 |
Labeler Name | Allergan, Inc. |
Substance Name | ESTRADIOL |
Active Ingredient Strength | 1 mg/1 |
Pharm Classes | Estradiol Congeners [CS],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2011-12-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA040197 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-12-26 |
Ingredient | Strength |
---|---|
ESTRADIOL | 1 mg/1 |
SPL SET ID: | a3803ba3-4eee-4e2e-ac8c-821a4e6720cc |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0430-0722 | Estrace | Estrace |
0430-0720 | Estrace | Estrace |
0430-0721 | Estrace | Estrace |
0430-3754 | ESTRACE | ESTRACE |
50090-2321 | ESTRACE | ESTRACE |
0023-5885 | Alora | Estradiol |
0023-5886 | Alora | Estradiol |
0023-5887 | Alora | Estradiol |
0023-5888 | Alora | Estradiol |
0037-4801 | ELESTRIN | ESTRADIOL |
0037-4802 | ELESTRIN | ESTRADIOL |
0013-2150 | Estring | estradiol |
0078-0343 | Vivelle-Dot | estradiol |
0078-0344 | Vivelle-Dot | estradiol |
0078-0345 | Vivelle-Dot | estradiol |
0078-0346 | Vivelle-Dot | estradiol |
0078-0365 | Vivelle-Dot | estradiol |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ESTRACE 72454618 0976274 Live/Registered |
MEAD JOHNSON & COMPANY 1973-04-16 |